Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05198765 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Weight Loss Clinical Decision Support

Study acronym: WL-CDS
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Eligibility criteria expanded, about 8 words
  2. Minor Completion pushed from Apr 30, 2026 to Apr 30, 2027v12
  3. Minor Re-verified, no change to tracked fieldsv11
  4. Notable Primary completion date: Jan 2025 to Oct 31, 2025 Completion date: Apr 2026 to Apr 30, 2026v10 Show 1 more changeShow less
    • Completion date: Apr 2026 to Apr 30, 2026
  5. Minor Trial status: Enrolling by Invitation to Active, Not Recruitingv9
Show 7 earlier versionsHide 7 earlier versions
  1. Minor Re-verified, no change to tracked fieldsv8
  2. Minor Trial status: Recruiting to Enrolling by Invitation Site details revisedv7 Show 1 more changeShow less
    • Site details revised
  3. Minor Re-verified, no change to tracked fieldsv6
  4. Notable Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Apr 4, 2023 to Apr 19, 2023 · Secondary endpoints expanded, about 16 wordsv5 Show 3 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Apr 4, 2023 to Apr 19, 2023
    • Secondary endpoints expanded, about 16 words

    See this version in full on ClinicalTrials.gov ↗

  5. Minor Start date: Mar 2023 to Apr 4, 2023v4
  6. Notable Start date: Dec 2022 to Mar 2023v3
  7. Notable Primary completion date: Dec 2023 to Jan 2025v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
4,286 trials monitored
See 187 trials at risk
3,560 trials monitored
See 142 trials at risk
2,100 trials monitored
See 102 trials at risk
Despite steady increases in obesity prevalence, the more than 12 million obese U.S. adults with type 2 diabetes (T2DM) and severe obesity encounter a number of barriers to adopting effective surgical and pharmaceutical treatments, including: (a) both patients and primary care clinicians frequently underestimate the effectiveness and potential benefits of obesity treatments; and (b) both patients and clinicians typically lack access to evidence-based estimates of the patient-specific potential benefits and risks of appropriate obesity treatment options. This project addresses these important obstacles to evidence-based obesity care by providing accurate, patient-specific estimates of benefits and risks of various obesity treatment options to inform shared decision making about obesity treatment. In this project the study team will implement a scalable, web-based point-of-care decision-support intervention in primary care that provides patient-specific estimates of obesity treatment benefits and risks in a randomized trial in 40 primary care clinics with 15,810 eligible patients, and assess intervention impact on (i) appropriate active management of obesity in eligible patients, (ii) weight trajectories, and (iii) patient and clinician satisfaction with the decision support intervention.
Trial Details
NCT Number NCT05198765
Lead Sponsor HealthPartners Institute
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions Diabetes Mellitus, Type 2, Obesity
Enrollment 10,120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov